TCF4 (e2-2; ITF2): A schizophrenia-associated gene with pleiotropic effects on human disease

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 1, 2013, Pages 1-16

  Navarrete, Katherinne ^a   Pedroso, Inti ^a   De Jong, Simone ^b   Stefansson, Hreinn ^c   Steinberg, Stacy ^c   Stefansson, Kari ^c,d   Ophoff, Roel A ^b,e   Schalkwyk, Leonard C ^a   Collier, David A ^a,f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DECODE GENETICS   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f ELI LILLY AND COMPANY   (United States)

Author keywords

Fuch's corneal dystrophy; Gene network; Genome wide association; Pitt Hopkins syndrome; Protein protein interaction

Indexed keywords

CALMODULIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MICRORNA 221; MICRORNA 222; PROTEIN; PROTEIN NEURO D2; PROTEIN TRANSCRIPTION FACTOR 4; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR E2 2A; TRANSCRIPTION FACTOR E2 2B; TRANSCRIPTION FACTOR MASH1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING SITE; BIOINFORMATICS; BRAIN DISEASE; CALCIUM CELL LEVEL; CANCER INVASION; CONGENITAL CORNEA DYSTROPHY; COPY NUMBER VARIATION; DNA BINDING; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE DELETION; GENE EXPRESSION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GROWTH RETARDATION; HUMAN; MISSENSE MUTATION; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEOTIDE SEQUENCE; NULL ALLELE; PITT HOPKINS SYNDROME; PLASMACYTOID DENDRITIC CELL; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TRANSCRIPTION FACTOR 4 GENE; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; GENETIC ASSOCIATION STUDIES; GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROTEIN INTERACTION MAPS; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

VERTEBRATA;

EID: 84871281959     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32109     Document Type: Review

References (157)

1. Abu-Elneel K, Liu T, Gazzaniga FS, Nishimura Y, Wall DP, Geschwind DH, Lao K, Kosik KS. 2008. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 9: 153- 161.
2. Akazawa C, Ishibashi M, Shimizu C, Nakanishi S, Kageyama R. 1995. A mammalian helix-loop-helix factor structurally related to the product of drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system. J Biol Chem 270: 8730- 8738.
3. Alkelai A, Greenbaum L, Lupoli S, Kohn Y, Sarner-Kanyas K, Ben-Asher E, Lancet D, Macciardi F, Lerer B. 2012. Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample. PLoS ONE 7(1): e29228.
4. Amaral FC, Torres N, Saggioro F, Neder L, Machado HR, Silva WA Jr, Moreira AC, Castro M. 2009. MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J Clin Endocrinol Metab 94: 320- 323.
5. Amiel J, Rio M, de Pontual L, Redon R, Malan V, Boddaert N, Plouin P, Carter NP, Lyonnet S, Munnich A, et al. 2007. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet 80: 988- 993.
6. Appaiah H, Bhat-Nakshatri P, Mehta R, Thorat M, Badve S, Nakshatri H. 2010. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer. Cancer Biol Ther 10: 600- 614.
7. Baratz KH, Tosakulwong N, Ryu E, Brown WL, Branham K, Chen W, Tran KD, Schmid-Kubista KE, Heckenlively JR, Swaroop A, et al. 2010. E2-2 protein and Fuchs's corneal dystrophy. N Engl J Med 363: 1016- 1024.
8. Barnes MR, Huxley-Jones J, Maycox PR, Lennon M, Thornber A, Kelly F, Bates S, Taylor A, Reid J, Jones N, et al. 2011. Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. J Neurosci Res 89: 1218- 1227.
9. Ben-Arie N, McCall AE, Berkman S, Eichele G, Bellen HJ, Zoghbi HY. 1996. Evolutionary conservation of sequence and expression of the bHLH protein Atonal suggests a conserved role in neurogenesis. Hum Mol Genet 5: 1207- 1216.
10. Ben-Arie N, Bellen HJ, Armstrong DL, McCall AE, Gordadze PR, Guo Q, Matzuk MM, Zoghbi HY. 1997. Math1 is essential for genesis of cerebellar granule neurons. Nature 390: 169- 172.
11. Bergqvist I, Eriksson M, Saarikettu J, Eriksson B, Corneliussen B, Grundstrom T, Holmberg D. 2000. The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development. Eur J Immunol 30: 2857- 2863.
12. Blake DJ, Forrest M, Chapman RM, Tinsley CL, O'Donovan MC, Owen MJ. 2010. TCF4, schizophrenia, and Pitt-Hopkins syndrome. Schizophr Bull 36: 443- 447.
13. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, Nekrutenko A, Taylor J. 2010. Galaxy: A web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol 10: 1- 21.
14. Boyer P, Phillips JL, Rousseau FL, Ilivitsky S. 2007. Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia. Brain Res Rev 54: 92- 112.
15. Brockschmidt A, Todt U, Ryu S, Hoischen A, Landwehr C, Birnbaum S, Frenck W, Radlwimmer B, Lichter P, Engels H, et al. 2007. Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. Hum Mol Genet 16: 1488- 1494.
16. Brockschmidt A, Filippi A, Issa P, Charbel P, Nelles M, Urbach H, Eter N, Driever W, Weber RG. 2011. Neurologic and ocular phenotype in Pitt-Hopkins syndrome and a zebrafish model. Hum Genet 130: 645- 655.
17. Brody JR, Witkiewicz AK. 2010. CXCR4 signaling identifies a role for IFT2 in ER-negative breast cancers. Cancer Biol Ther 10(6): 615- 616.
18. Brzozka MM, Radyushkin K, Wichert SP, Ehrenreich H, Rossner MJ. 2010. Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry 68: 33- 40.
19. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. 2002. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159: 539- 545.
20. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, et al. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613- 618.
21. Casanova MF, Kreczmanski P, Trippe J II, Switala A, Heinsen H, Steinbusch HW, Schmitz C. 2008. Neuronal distribution in the neocortex of schizophrenic patients. Psychiatry Res 158: 267- 277.
22. Cervantes-Barragan L, Lewis KL, Firner S, Thiel V, Hugues S, Reith W, Ludewig B, Reizis B. 2012. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci USA 109: 3012- 3017.
23. Chandrasekar V, Dreyer JL. 2009. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci 42: 350- 362.
24. Cisse B, Caton M, Lehner M, Maeda T, Scheu S, Locksley R, Holmberg D, Zweier C, Denhollander N, Kant S. 2008. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135: 37- 48.
25. Conti A, Aguennouz M, La Torre D, Tomasello C, Cardali S, Angileri FF, Maio F, Cama A, Germano A, Vita G, et al. 2009. miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol 93: 325- 332.
26. Corneliussen B, Thornell A, Hallberg B, Grundstrom T. 1991. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J Virol 65: 6084- 6093.
27. Corneliussen B, Holm M, Waltersson Y, Onions J, Hallberg B, Thornell A, Grundstrom T. 1994. Calcium/calmodulin inhibition of basic-helix-loop-helix transcription factor domains. Nature 368: 760- 764.
28. Cotter D, Kerwin R, Al-Sarraji S, Brion JP, Chadwich A, Lovestone S, Anderton B, Everall I. 1998. Abnormalities of Wnt signalling in schizophrenia-evidence for neurodevelopmental abnormality. Neuroreport 9: 1379- 1383.
29. de Pontual LC, Mathieu Y, Golzio C, Rio MN, Malan VR, Boddaert N, Soufflet C, Picard C, Durandy A, Dobbie A, et al. 2009. Mutational, functional, and expression studies of theTCF4 gene in Pitt-Hopkins syndrome. Hum Mutat 30: 669- 676.
30. de Pooter RF, Kee BL. 2010. E proteins and the regulation of early lymphocyte development. Immunol Rev 238: 93- 109.
31. Dweep H, Sticht C, Pandey P, Gretz N. 2011. miRWalk-database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44: 839- 847.
32. Dworkin S, Mantamadiotis T. 2010. Targeting CREB signalling in neurogenesis. Expert Opin Ther Targets 14: 869- 879.
33. Eastwood SL. 2004. The synaptic pathology of schizophrenia: Is aberrant neurodevelopment and plasticity to blame? Int Rev Neurobiol 59: 47- 72.
34. Einarson MB, Chao MV. 1995. Regulation of Id1 and its association with basic helix-loop-helix proteins during nerve growth factor-induced differentiation of PC12 cells. Mol Cell Biol 15: 4175- 4183.
35. Emanuelsson O, Brunak S, von Heijne G, Nielsen H. 2007. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2: 953- 971.
36. Engel I, Murre C. 2001. The function of E- and Id proteins in lymphocyte development. Nat Rev Immunol 1: 193- 199.
37. Ernst A, Campos B, Meier J, Devens F, Liesenberg F, Wolter M, Reifenberger G, Herold-Mende C, Lichter P, Radlwimmer B. 2010. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 29: 3411- 3422.
38. Euskirchen GM, Rozowsky JS, Wei CL, Lee WH, Zhang ZD, Hartman S, Emanuelsson O, Stolc V, Weissman S, Gerstein MB, et al. 2007. Mapping of transcription factor binding regions in mammalian cells by ChIP: Comparison of array- and sequencing-based technologies. Genome Res 17: 898- 909.
39. Evangelisti C, Florian MC, Massimi I, Dominici C, Giannini G, Galardi S, Bue MC, Massalini S, McDowell HP, Messi E, et al. 2009. MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J 23: 4276- 4287.
40. Farah MH, Olson JM, Sucic HB, Hume RI, Tapscott SJ, Turner DL. 2000. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development 127: 693- 702.
41. Flora A, Garcia JJ, Thaller C, Zoghbi HY. 2007. The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc Natl Acad Sci 104: 15382- 15387.
42. Frazer KA, Pachter L, Poliakov A, Rubin EM, Dubchak I. 2004. VISTA: Computational tools for comparative genomics. Nucleic Acids Res 32: W273- W279.
43. Freyberg Z, Ferrando SJ, Javitch JA. 2010. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry 167: 388- 396.
44. Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, Faas BH, Knoers NV, Cahn W, Kahn RS, Edelmann L, et al. 2008. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 13: 261- 266.
45. Fu H, Cai J, Clevers H, Fast E, Gray S, Greenberg R, Jain MK, Ma Q, Qiu M, Rowitch DH, Taylor CM, Stiles CD. 2009. A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. J Neurosci 29: 11399- 11408.
46. Furumura M. 2001. Involvement of ITF2 in the transcriptional regulation of melanogenic genes. J Biol Chem 276: 28147- 28154.
47. Gao Z, Ure K, Ding P, Nashaat M, Yuan L, Ma J, Hammer RE, Hsieh J. 2011. The master negative regulator REST/NRSF controls adult neurogenesis by restraining the neurogenic program in quiescent stem cells. J Neurosci 31: 9772- 9786.
48. Geschwind DH, Konopka G. 2009. Neuroscience in the era of functional genomics and systems biology. Nature 461: 908- 915.
49. Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B. 2010. Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 33: 905- 916.
50. Gohlke JM, Armant O, Parham FM, Smith MV, Zimmer C, Castro DS, Nguyen L, Parker JS, Gradwohl G, Portier CJ, et al. 2008. Characterization of the proneural gene regulatory network during mouse telencephalon development. BMC Biol 6: 15.
51. Gross J, Grimm O, Meyer J, Lesch KP. 2003. The cadherin hypothesis of schizophrenia. Fortschr Neurol Psychiatr 71: 84- 88.
52. Gustavsson P, Kimber E, Wahlstrom J, Anneren G. 1999. Monosomy 18q syndrome and atypical Rett syndrome in a girl with an interstitial deletion (18)(q21.1q22.3). Am J Med Genet 82: 348- 351.
53. Hansen T, Ingason A, Djurovic S, Melle I, Fenger M, Gustafsson O, Jakobsen KD, Rasmussen HB, Tosato S, Rietschel M, et al. 2011. At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol Psychiatry 70: 59- 63.
54. Harada R, Vadnais C, Sansregret L, Leduy L, Berube G, Robert F, Nepveu A. 2008. Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes. Nucleic Acids Res 36: 189- 202.
55. Harrison PJ. 2004. The hippocampus in schizophrenia: A review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174: 151- 162.
56. Hayashi-Takagi A, Sawa A. 2010. Disturbed synaptic connectivity in schizophrenia: Convergence of genetic risk factors during neurodevelopment. Brain Res Bull 83: 140- 146.
57. Hebert SS, Horre K, Nicolai L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B. 2009. MicroRNA regulation of Alzheimer's amyloid precursor protein expression. Neurobiol Dis 33: 422- 428.
58. Heckers S. 1997. Neuropathology of schizophrenia: Cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr Bull 23: 403- 421.
59. Henthorn P, Carrick-Walmsley R, Kadesch T. 1990. Sequence of the cDNA encoding ITF-2, a positive-acting transcription factor. Nucleic Acids Res 18: 678.
60. Herbst A, Kolligs F. 2008. A conserved domain in the transcription factor ITF-2B attenuates its activity. Biochem Biophys Res Commun 370: 327- 331.
61. Ince-Dunn G, Hall BJ, Hu SC, Ripley B, Huganir RL, Olson JM, Tapscott SJ, Ghosh A. 2006. Regulation of thalamocortical patterning and synaptic maturation by NeuroD2. Neuron 49: 683- 695.
62. Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, Ban MR, Martins RA, Kennedy BA, Hassell RG, Visser ME, et al. 2010. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 42: 684- 687.
63. Johnson MB, Kawasawa YI, Mason CE, Krsnik Z, Coppola G, Bogdanovic D, Geschwind DH, Mane SM, State MW, Sestan N. 2009. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 62: 494- 509.
64. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G, et al. 2011. Spatio-temporal transcriptome of the human brain. Nature 478: 483- 489.
65. Kolligs FT, Nieman MT, Winer I, Hu G, Van Mater D, Feng Y, Smith IM, Wu R, Zhai Y, Cho KR, et al. 2002. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell 1: 145- 155.
66. Kuot A, Hewitt AW, Griggs K, Klebe S, Mills R, Jhanji V, Craig JE, Sharma S, Burdon KP. 2012. Association of TCF4 and CLU polymorphisms with Fuchs' endothelial dystrophy and implication of CLU and TGFBI proteins in the disease process. Eur J Hum Genet 20: 632- 638.
67. Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, et al. 2011. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry 16: 37- 58.
68. Kwon E, Wang W, Tsai LH. 2011. Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol Psychiatry December 20. DOI: 10.1038/mp.2011.170. [Epub ahead of print]
69. la Cour T, Kiemer L, Molgaard A, Gupta R, Skriver K, Brunak S. 2004. Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel 17: 527- 536.
70. Lang GK, Naumann GO. 1987. The frequency of corneal dystrophies requiring keratoplasty in Europe and the U.S.A. Cornea 6: 209- 211.
71. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, et al. 2009. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55: 1977- 1983.
72. Lavon I, Zrihan D, Granit A, Einstein O, Fainstein N, Cohen MA, Zelikovitch B, Shoshan Y, Spektor S, Reubinoff BE, et al. 2010. Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro Oncol 12: 422- 433.
73. Lazorchak A, Jones ME, Zhuang Y. 2005. New insights into E-protein function in lymphocyte development. Trends Immunol 26: 334- 338.
74. Lewis DA, Gonzalez-Burgos G. 2008. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33: 141- 165.
75. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15- 20.
76. Li Y, Li W, Yang Y, Lu Y, He C, Hu G, Liu H, Chen J, He J, Yu H. 2009. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 1286: 13- 18.
77. Li YJ, Minear MA, Rimmler J, Zhao B, Balajonda E, Hauser MA, Allingham RR, Eghrari AO, Riazuddin SA, Katsanis N, Gottsch JD, Gregory SG, Klintworth GK, Afshari NA. 2011. Replication of TCF4 through association and linkage studies in late-onset Fuchs endothelial corneal dystrophy. PLoS One 6(4): e18044.
78. Lin CH, Tapscott SJ, Olson JM. 2006. Congenital hypothyroidism (cretinism) in neuroD2-deficient mice. Mol Cell Biol 26: 4311- 4315.
79. Liu Y, Ray SK, Yang XQ, Luntz-Leybman V, Chiu IM. 1998. A splice variant of E2-2 basic helix-loop-helix protein represses the brain-specific fibroblast growth factor 1 promoter through the binding to an imperfect E-box. J Biol Chem 273: 19269- 19276.
80. Liu DZ, Tian Y, Ander BP, Xu H, Stamova BS, Zhan X, Turner RJ, Jickling G, Sharp FR. 2010. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 30: 92- 101.
81. Lu R, Qu Y, Ge J, Zhang L, Su Z, Pflugfelder SC, Li DQ. 2012. Transcription factor TCF4 maintains the properties of human corneal epithelial stem cells. Stem Cells 30(4): 753- 761.
82. Lynch M. 2007. The frailty of adaptive hypotheses for the origins of organismal complexity. Proc Natl Acad Sci USA 104( Suppl 1): 8597- 8604.
83. Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R, Barnes MR, Larminie C, Jones N, Lennon M, et al. 2009. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 14: 1083- 1094.
84. McInnis MG, Swift-Scanlanl T, Mahoney AT, Vincent J, Verheyen G, Lan TH, Oruc L, Riess O, Van Broeckhoven C, Chen H, et al. 2000. Allelic distribution of CTG18.1 in Caucasian populations: Association studies in bipolar disorder, schizophrenia, and ataxia. Mol Psychiatry 5: 439- 442.
85. Meek KM, Leonard DW, Connon CJ, Dennis S, Khan S. 2003. Transparency, swelling and scarring in the corneal stroma. Eye (Lond) 17: 927- 936.
86. Merz K, Herold S, Lie DC. 2011. CREB in adult neurogenesis-master and partner in the development of adult-born neurons? Eur J Neurosci 33: 1078- 1086.
87. Miyaoka T, Seno H, Ishino H. 1999. Increased expression of Wnt-1 in schizophrenic brains. Schizophr Res 38: 1- 6.
88. Mudge J, Miller NA, Khrebtukova I, Lindquist IE, May GD, Huntley JJ, Luo S, Zhang L, van Velkinburgh JC, Farmer AD, et al. 2008. Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS ONE 3(11): e3625.
89. Muir T, Sadler-Riggleman I, Stevens JD, Skinner MK. 2006. Role of the basic helix-loop-helix protein ITF2 in the hormonal regulation of Sertoli cell differentiation. Mol Reprod Dev 73: 491- 500.
90. Murre C. 2005. Helix-loop-helix proteins and lymphocyte development. Nat Immunol 6(11): 1079- 1086.
91. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, et al. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58: 537- 544.
92. Nagasawa M, Schmidlin H, Hazekamp MG, Schotte R, Blom B. 2008. Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 the Ets factor Spi-B. Eur J Immunol 38: 2389- 2400.
93. Narayan S, Tang B, Head SR, Gilmartin TJ, Sutcliffe JG, Dean B, Thomas EA. 2008. Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res 1239: 235- 248.
94. Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, et al. 2009. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 19: 375- 383.
95. Noda T, Kawamura R, Funabashi H, Mie M, Kobatake E. 2006. Transduction of NeuroD2 protein induced neural cell differentiation. J Biotechnol 126: 230- 236.
96. Northcott PA, Fernandez LA, Hagan JP, Ellison DW, Grajkowska W, Gillespie Y, Grundy R, Van Meter T, Rutka JT, Croce CM, et al. 2009. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 69: 3249- 3255.
97. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D, International Schizophrenia Consortium, Corvin A. 2011. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16(3): 286- 292.
98. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. 2008. Functional organization of the transcriptome in human brain. Nat Neurosci 11: 1271- 1282.
99. Olson JM, Asakura A, Snider L, Hawkes R, Strand A, Stoeck J, Hallahan A, Pritchard J, Tapscott SJ. 2001. NeuroD2 is necessary for development and survival of central nervous system neurons. Dev Biol 234: 174- 187.
100. Orrico A, Galli L, Zappella M, Lam CW, Bonifacio S, Torricelli F, Hayek G. 2001. Possible case of Pitt-Hopkins syndrome in sibs. Am J Med Genet 103(2): 157- 159.
101. Othman A, Frim DM, Polak P, Vujicic S, Arnason BG, Boullerne AI. 2011. Olig1 is expressed in human oligodendrocytes during maturation and regeneration. Glia 59: 912- 926.
102. Ozsolak F, Milos PM. 2011. RNA sequencing: Advances, challenges and opportunities. Nat Rev Genet 12: 87- 98.
103. Panman L, Andersson E, Alekseenko Z, Hedlund E, Kee N, Mong J, Uhde CW, Deng Q, Sandberg R, Stanton LW, Ericson J, Perlmann T. 2011. Transcription factor-induced lineage selection of stem-cell-derived neural progenitor cells. Cell Stem Cell 8: 663- 675.
104. Peippo MM, Simola KO, Valanne LK, Larsen AT, Kahkonen M, Auranen MP, Ignatius J. 2006. Pitt-Hopkins syndrome in two patients and further definition of the phenotype. Clin Dysmorphol 15: 47- 54.
105. Pemberton LF, Paschal BM. 2005. Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 6: 187- 198.
106. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM. 2007. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8: R27.
107. Persson P, Jogi A, Grynfeld A, Pahlman S, Axelson H. 2000. HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. Biochem Biophys Res Commun 274: 22- 31.
108. Petropoulos H. 2000. Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47. J Biol Chem 275: 25095- 25101.
109. Pickard BS, Millar JK, Porteous DJ, Muir WJ, Blackwood DH. 2005. Cytogenetics and gene discovery in psychiatric disorders. Pharmacogenomics J 5: 81- 88.
110. Pidsley R, Mill J. 2011. Epigenetic studies of psychosis: Current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry 69: 146- 156.
111. Pierson J, Hostager B, Fan R, Vibhakar R. 2008. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 90: 1- 7.
112. Pitt D, Hopkins I. 1978. A syndrome of mental retardation, wide mouth and intermittent overbreathing. Aust Paediatr J 14: 182- 184.
113. Poethig RS. 2009. Small RNAs and developmental timing in plants. Curr Opin Genet Dev 19: 374- 378.
114. Pscherer A, Dorflinger U, Kirfel J, Gawlas K, Ruschoff J, Buettner R, Schule R. 1996. The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J 15: 6680- 6690.
115. Quednow BB, Ettinger U, Mössner R, Rujescu D, Giegling I, Collier DA, Schmechtig A, Kühn KU, Möller HJ, Maier W, Wagner M, Kumari V. 2011. The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci 31: 6684- 6691.
116. Quednow BB, Brinkmeyer J, Mobascher A, Nothnagel M, Musso F, Gründer G, Savary N, Petrovsky N, Frommann I, Lennertz L, Spreckelmeyer KN, Wienker TF, Dahmen N, Thuerauf N, Clepce M, Kiefer F, Majic T, Mössner R, Maier W, Gallinat J, Diaz-Lacava A, Toliat MR, Thiele H, Nürnberg P, Wagner M, Winterer G. 2012. Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proc Natl Acad Sci USA 109: 6271- 6276.
117. Quong MW, Romanow WJ, Murre C. 2002. E protein function in lymphocyte development. Annu Rev Immunol 20: 301- 322.
118. Ravanpay AC, Olson JM. 2008. E protein dosage influences brain development more than family member identity. J Neurosci Res 86: 1472- 1481.
119. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K, Akalin A, Schmeier S, Kanamori-Katayama M, Bertin N, et al. 2010. An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140: 744- 752.
120. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA, Lin DY, Duan J, Ophoff RA, Andreassen OA, et al. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969- 976.
121. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, et al. 2007. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 4: 651- 657.
122. Ross SE, Greenberg ME, Stiles CD. 2003. Basic helix-loop-helix factors in cortical development. Neuron 39: 13- 25.
123. Rossbach M. 2011. Non-coding RNAs in neural networks, REST-assured. Front Genet 2: 8.
124. Rozowsky J, Euskirchen G, Auerbach RK, Zhang ZD, Gibson T, Bjornson R, Carriero N, Snyder M, Gerstein MB. 2009. PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls. Nat Biotechnol 27: 66- 75.
125. Rujescu D, Collier DA. 2009. Dissecting the many genetic faces of schizophrenia. Epidemiol Psichiatr Soc 18: 91- 95.
126. Saarikettu J. 2004. Calcium/calmodulin inhibition of transcriptional activity of E-proteins by prevention of their binding to DNA. J Biol Chem 279: 41004- 41011.
127. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA. 2008. A miRNA signature of prion induced neurodegeneration. PLoS ONE 3(11): e3652.
128. Sepp M, Kannike K, Eesmaa A, Urb M, Timmusk T. 2011. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5' exon usage and splicing. PLoS ONE 6: e22138.
129. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE. 2007. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: A mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81: 405- 413.
130. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, et al. 2008. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14.
131. Singh HA. 1993. Mental retardation, macrostomia and hyperpnoea syndrome. J Paediatr Child Health 29: 156- 157.
132. Skerjanc IS, Truong J, Filion P, McBurney MW. 1996. A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity. J Biol Chem 271: 3555- 3561.
133. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N, Edenberg HJ, Nurnberger JI Jr, Rietschel M, Blackwood D, et al. 2011. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43: 977- 983.
134. Sobrado VR, Moreno-Bueno G, Cubillo E, Holt LJ, Nieto MA, Portillo F, Cano A. 2009. The class I bHLH factors E2-2A and E2-2B regulate EMT. J Cell Sci 122: 1014- 1024.
135. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460: 744- 747.
136. Steinberg S, de Jong S, Andreassen OA, Werge T, Borglum AD, Mors O, Mortensen PB, Gustafsson O, Costas J, Pietilainen OP, et al. 2011. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 20: 4076- 4081.
137. Stephan KE, Friston KJ, Frith CD. 2009. Dysconnection in schizophrenia: From abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull 35: 509- 527.
138. Talebizadeh Z, Butler MG, Theodoro MF. 2008. Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res 1: 240- 250.
139. Thierry-Mieg D, Thierry-Mieg J. 2006. AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7( Suppl 1): S12- S14.
140. Uziel T, Karginov FV, Xie S, Parker JS, Wang YD, Gajjar A, He L, Ellison D, Gilbertson RJ, Hannon G, et al. 2009. The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci USA 106: 2812- 2817.
141. Van Balkom ID, Quartel S, Hennekam RC. 1998. Mental retardation, "coarse" face, and hyperbreathing: Confirmation of the Pitt-Hopkins syndrome. Am J Med Genet 75: 273- 276.
142. van Os J, Kapur S. 2009. Schizophrenia. Lancet 374: 635- 645.
143. Vawter MP. 2000. Dysregulation of the neural cell adhesion molecule and neuropsychiatric disorders. Eur J Pharmacol 405: 385- 395.
144. Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M, Pritchard JK. 2008. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 4: e1000214.
145. Visel A, Minovitsky S, Dubchak I, Pennacchio LA. 2007. VISTA enhancer browser-A database of tissue-specific human enhancers. Nucleic Acids Res 35: D88- D92.
146. Wang VY, Rose MF, Zoghbi HY. 2005. Math1 expression redefines the rhombic lip derivatives and reveals novel lineages within the brainstem and cerebellum. Neuron 48: 31- 43.
147. Watowich SS, Liu YJ. 2010. Mechanisms regulating dendritic cell specification and development. Immunol Rev 238: 76- 92.
148. Whalen S, Heron D, Gaillon T, Moldovan O, Rossi M, Devillard F, Giuliano F, Soares G, Mathieu-Dramard M, Afenjar A, et al. 2012. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: Clinical score and further delineation of the TCF4 mutational spectrum. Hum Mutat 33: 64- 72.
149. Wikstrom I, Forssell J, Penha-Goncalves MN, Bergqvist I, Holmberg D. 2008. A role for E2-2 at the DN3 stage of early thymopoiesis. Mol Immunol 45: 3302- 3311.
150. Williams HJ, Craddock N, Russo G, Hamshere ML, Moskvina V, Dwyer S, Smith RL, Green E, Grozeva D, Holmans P, et al. 2011a. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet 20: 387- 391.
151. Williams HJ, Moskvina V, Smith RL, Dwyer S, Russo G, Owen MJ, O'Donovan MC. 2011b. Association between TCF4 and schizophrenia does not exert its effect by common nonsynonymous variation or by influencing cis-acting regulation of mRNA expression in adult human brain. Am J Med Genet Part B Neuropsychiatr Genet 156B: 781- 784.
152. Yoon SO, Chikaraishi DM. 1994. Isolation of two E-box binding factors that interact with the rat tyrosine hydroxylase enhancer. J Biol Chem 269: 18453- 18462.
153. Zaghloul NA, Katsanis N. 2010. Functional modules, mutational load and human genetic disease. Trends Genet 26: 168- 176.
154. Zhang C. 2009. MicroRNA and vascular smooth muscle cell phenotype: New therapy for atherosclerosis? Genome Med 1(9): 85.
155. Zierhut K, Bogerts B, Schott B, Fenker D, Walter M, Albrecht D, Steiner J, Schutze H, Northoff G, Duzel E, et al. 2010. The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Res 183: 187- 194.
156. Zweier C. 2007. Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80: 994- 1001.
157. Zweier C, de Jong EK, Zweier M, Orrico A, Ousager LB, Collins AL, Bijlsma EK, Oortveld MAW, Ekici AB, Reis A. 2009. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in drosophila. Am J Hum Genet 85: 655- 666.